Researchers developed bispecific antibodies bsAbs CoV2 biRN5 and CoV-biRN7 from convalescent COVID-19 donors that show broad neutralization potency against Omicron variants. These antibodies, comprising N-terminal domain (NTD) and receptor binding domain (RBD), could replace current COVID-19 interventions, which are losing effectiveness due to virus evolution. These findings may form the basis for new effectively neutralizing COVID-19 vaccines and antibody-based therapeutics.
- Ten Major Zero-day Attacks that Made Headlines in 2023
- The Biggest Zero-day Cyber Attacks of 2023: Top 10 Review
- A Look at the Top Ten Zero-day Attacks in 2023
- 2023’s Gravest Zero-day Attacks: The Top 10 Cases
- 2023’s Most Impressive Zero-Day Attacks: The Biggest 10
- Recap: The 10 Most Massive Zero-day Cyber-Attacks in 2023
- Top Ten Unprecedented Zero-day Attacks of the Year 2023
- A Review of the Biggest Zero-Day Offenses of 2023: Top 10
- An Overview of the 10 Most Significant Zero-Day Attacks in 2023
- The Ten Most Notably Large Zero-Day Attacks in 2023.
Hey, Bay Area healthcare pros! Let’s talk cybersecurity. Remember when zero-day vulnerabilities were the big security scare back in 2023? Yeah, those were rough times.
